Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship [Yahoo! Finance]
Aspire Biopharma Holdings, Inc. (ASBP)
Company Research
Source: Yahoo! Finance
ESTERO, FL / ACCESS Newswire / February 25, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced a massive expansion of its social media and digital marketing footprint for its wholly owned subsidiary, Buzz Bomb Caffeine Company. The initiative follows a successful strategic rebranding and a high-profile sponsorship of professional ultra-marathoner Ashley Paulson, whose recent world-record performance catalyzed a significant increase in brand visibility and consumer acquisition. BUZZ BOMB™-a caffeine supplement delivering a precise 50mg serving in convenient and flavorful stick packs-has seen its social media content surpass 400,000 views in a 48-hour period after the race. This digital momentum coincides with the brand's recent evolution, featuring a sleek modern website and science-forward packaging designed to appeal to high-performance athletes and everyday consumers alike. The brand's visibility reached a fever pitch at the 2026 J
Show less
Read more
Impact Snapshot
Event Time:
ASBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASBP alerts
High impacting Aspire Biopharma Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ASBP
News
- Aspire Biopharma regains Nasdaq minimum bid price compliance [Seeking Alpha]Seeking Alpha
- Aspire Biopharma (NASDAQ:ASBP) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Aspire Biopharma (NASDAQ:ASBP) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ASBP&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street ZMarketBeat
- BC-Most Active Stocks [Yahoo! Finance]Yahoo! Finance
- Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA) [Yahoo! Finance]Yahoo! Finance
ASBP
Sec Filings
- 2/24/26 - Form DEF
- 2/17/26 - Form S-1
- 2/12/26 - Form PRE
- ASBP's page on the SEC website